GPER1 knockdown has been shown to negate the effects of G-1 and tamoxifen, indicating a GPER1-dependent pathway and suggesting that GPER1 activation exerts anti-proliferative effects in melanoma [30]. This evidence concerns the gene GPER1 and melanoma.